MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
MIST — Milestone Pharmaceuticals Inc. Common Shares
NasdaqMilestone Pharmaceuticals Inc. Common Shares
$0.76
-0.02(-1.95%)
- O
- 0.80
- H
- 0.82
- L
- 0.76
- V
- 1.38M
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About MIST
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateMay 9, 2019
Employees38
Stock ExchangeNasdaq
Ticker SymbolMIST
Key Financial Statistics
| Market Cap | $100.81M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.75 - $3.06 |
| 52-Week Avg Volume | 2.55M |
| VWAP | $0.78 |
| Transactions | 4,122 |
| Total Recorded Bars | 1,863 days |